Trazodone in the treatment of psychoneuroses: a double-blind study.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003291:Conversion Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011596:Psychomotor Disorders / Q000188:drug therapy; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use*; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013997:Time Factors; D014230:Triazoles / Q000627:therapeutic use
D000928:Antidepressive Agents; D010879:Piperazines; D010919:Placebos; D011725:Pyridines; D014230:Triazoles